India: MSF supports the introduction and roll-out of single-dose treatment for kala azar in Bihar State
Vaishali, Delhi, Nairobi, November 17, 2014: From this day on, treatment for kala azar will only take two hours. Single-dose liposomal amphotericin B, commonly referred to as SD LAmB, has now been made...
Last updated 17 November 2014
© Martin Zinggl/MSF
Last updated 13 November 2014
Guinea, Photo by Julien Rey/MSF
Last updated 24 October 2014
Mexico City/ October 1st- The 43,000 inhabitants in San Pedro Pochutla and Mazunte, Oaxaca State, Mexico, have access to diagnosis and treatment for Chagas in primary healthcare facilities. The Oaxaca...
Last updated 1 October 2014
MSF urges Prime Minister Modi to resist US political pressure to restrict global access to medicines
Last updated 26 September 2014
“I can also serve as an inspiration” – a role for social media in supporting patients undergoing treatment for multidrug-resistant tuberculosis (MDR-TB)
Last updated 9 October 2014
On World Hepatitis Day, organisations call on SA government: protect infants with HepB jab at birth & reduce patent barriers to HepB therapies
July 28, 2014, JOHANNESBURG—On World Hepatitis Day, 26 organisations and individuals from around the world have called on the South African Department of Health (DOH) and Department of Trade and Industry...
Reduction in pricing still needed to ensure wider access to treatment
Melbourne, 21 July 2014 – High prices continue to represent a major barrier to affordable access of both new HIV medicines and viral load testing -- which is the best way to monitor whether treatment...